NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients.
Jandrey EHF, Moura RP, Andrade LNS, Machado CL, Campesato LF, Leite KRM, Inoue LT, Asprino PF, da Silva APM, de Barros ACSD, Carvalho A, de Lima VC, Carraro DM, Brentani HP, da Cunha IW, Soares FA, Parmigiani RB, Chammas R, Camargo AA, Costa ÉT.
Jandrey EHF, et al. Among authors: de barros acsd.
NPJ Breast Cancer. 2019 Apr 5;5:11. doi: 10.1038/s41523-019-0106-x. eCollection 2019.
NPJ Breast Cancer. 2019.
PMID: 30963110
Free PMC article.